Bullish
Johnson & Johnson's stock rises to $271.95 after positive Q2 2026 earnings report
Johnson & Johnson's stock price increased to $271.95 following the release of its Q2 2026 earnings report, which showed a 6.6% year-over-year sales growth to $25.3 billion and an adjusted earnings per share (EPS) of $2.90. The company also raised its 2026 sales and EPS guidance, reflecting strong operational performance.
Key points
- Q2 2026 sales grew 6.6% year-over-year to $25.3 billion, with adjusted EPS of $2.90.
- Raised 2026 sales guidance to $101.1 billion and adjusted EPS guidance to $11.68.
- Stock price reached $271.95, with an intraday high of $273.77 and low of $269.64.
Sources
AI-generated from public news sources. Not financial advice.
